Company news
Syntara Limited news in 2017
Syntara Limited's news releases, calls and decks from 2017, newest first.
Pharmaxis Acquires Control, Increases Stake in LOXL2 Program
December 13, 2017
Boehringer Initiating Phase 2a Study Diabetic Retinopathy
September 7, 2017
Antifibrotic LOXL2 Program Clears Preclinical Development
September 5, 2017
Boehringer Ingelheim Initiates Phase IIa Study in NASH
August 24, 2017
Positive Recommendation for Broader Bronchitol Access in Aus
August 18, 2017
Preliminary Final Report June 2017
August 10, 2017
Appendix 4C - quarterly June 2017
July 28, 2017
Pharmaxis Announces Results of Pivotal CF Clinical Trial
June 12, 2017
Pharmaxis Set to Generate Further Euro 10m Milestone Payment
May 14, 2017
Pharmaxis Appoints Chiesi as Bronchitol Distributor in Italy
May 8, 2017
Appendix 4C - quarterly cash flow
April 18, 2017
Quarterly Shareholder Update March 2017
April 17, 2017
Synairgen Collaboration Progress
March 12, 2017